Synteka Bio Inc. is a company in South Korea, with a head office in Daejeon. The enterprise currently operates in the Software Publishers sector. Synteka Bio Inc. was incorporated on September 15, 2009. There are currently 49 (2025) people employed by Synteka Bio Inc.. From the latest financial highlights, Synteka Bio Inc. reported a net sales revenue increase of 2736.73% in 2025. Its’ total assets recorded a growth of 6.45%. The net profit margin of Synteka Bio Inc. increased by 5460.12% in 2025.

Headquarters
512, B-Dong, 187, Techno 2-Ro, Yuseong-Gu, Daejeon
Daejeon; Daejeon;

Contact Details: Purchase the Synteka Bio Inc. report to view the information.

Website: http://www.syntekabio.com

Basic Information

Total Employees:

Purchase the Synteka Bio Inc. report to view the information.

Outstanding Shares:

Purchase the Synteka Bio Inc. report to view the information.

Registered Capital:

Purchase the Synteka Bio Inc. report to view the information.

Financial Auditors:

Purchase the Synteka Bio Inc. report to view the information.

Incorporation Date:

September 15, 2009

Key Executives

Purchase this report to view the information.

Chief Executive Officer

Subsidiaries

주)신테카바이오

Company Performance

Financial values in the chart are available after Synteka Bio Inc. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.

Net sales revenue

2736.73%▲

Total Operating Revenue

2636.48%▲

Operating Profit

-5.72%▼

EBITDA

27.28%▲

Net Profit/Loss for the Period

-140.92%▼

Total Assets

6.45%▲

Total Equity

27.41%▲

Operating Profit Margin

11494.32%▲

Net Profit Margin

5460.12%▲

Return on Equity (ROE)

-25.76%▼

Debt / Equity

-6.9%▼

Quick Ratio

0.65%▲

Cash Ratio

0.59%▲

Synteka Bio Inc. (South Korea)